Hospital
Lexington Hospital Corporation
Lexington Hospital Corporation was paid $4.74M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoLEXINGTON HOSPITAL CORPORATION
LEXINGTON, TN 38351
LEXINGTON, TN 38351
33aNPI1255302923assigned 01/30/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.74M
24GClaims140,041
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#42 of 71
Median peer was paid$6.96M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HENSON, LARRY controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,610 | $496K | |
| 2019 | 12,390 | $495K | |
| 2020 | 19,786 | $560K | |
| 2021 | 22,696 | $724K | |
| 2022 | 21,508 | $775K | |
| 2023 | 29,151 | $936K | |
| 2024incomplete | 21,900 | $754K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 16,145 | 14,405 | $1.65M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 9,463 | 8,325 | $1.18M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 5,289 | 4,454 | $899K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.2% | 4,246 | 3,949 | $340K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 2,562 | 2,390 | $97K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 14,961 | 12,365 | $78K |
| 80053 | Comprehensive metabolic panel | 1.0% | 13,417 | 11,172 | $49K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,103 | 978 | $46K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,142 | 7,170 | $40K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,069 | 890 | $38K |
| 84484 | <1% | 2,937 | 2,307 | $32K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 452 | 428 | $30K |
70 more codes
| 87276 | <1% | 2,344 | $23K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,267 | $22K |
| 87275 | <1% | 2,799 | $19K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,487 | $18K |
| 87430 | <1% | 1,422 | $17K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,679 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 850 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,262 | $12K |
| 83690 | <1% | 2,179 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,225 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,899 | $10K |
| 82150 | <1% | 1,889 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,849 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,762 | $6K |
| 83735 | <1% | 1,333 | $6K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 22 | $5K |
| 81025 | <1% | 1,292 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 319 | $5K |
| 80061 | Lipid panel | <1% | 461 | $5K |
| G0378 | Hospital observation service, per hour | <1% | 122 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 437 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 172 | $4K |
| 81003 | <1% | 4,160 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 74 | $3K |
| 81001 | <1% | 2,832 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 517 | $3K |
| 83880 | <1% | 365 | $2K | |
| 87280 | <1% | 159 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 75 | $2K |
| 80306 | <1% | 210 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 282 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 108 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $858.63 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $743.49 |
| 94760 | <1% | 362 | $699.01 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 318 | $659.71 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 29 | $589.54 |
| 83605 | <1% | 74 | $554.58 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 167 | $438.38 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $325.10 |
| 87210 | <1% | 55 | $309.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 691 | $249.76 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 63 | $247.06 |
| 74018 | <1% | 18 | $204.97 | |
| 82607 | <1% | 20 | $197.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $170.21 |
| 73630 | <1% | 14 | $136.44 | |
| 85027 | <1% | 55 | $103.64 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 138 | $69.75 |
| 73030 | <1% | 14 | $48.36 | |
| 84439 | <1% | 13 | $39.00 | |
| 99000 | <1% | 238 | $37.72 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 118 | $35.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,658 | $16.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,207 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 313 | $0.00 |
| A9270 | Non-covered item or service | 0% | 141 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 37 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 66 | $0.00 |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 164 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 2,022 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 114 | $0.00 |
| C1780 | Lens, intraocular (new technology) | 0% | 39 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 55 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 33 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 22 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 22 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 14 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENSON, LARRY (RCD)
| Provider | Location | Paid |
|---|---|---|
| Lexington Hospital Corporation | Lexington, TN | $2.24M |
| Ambulance Services of Lexington, INC. | Lexington, TN | $2.02M |
| Roland Public Schools | Roland, OK | $574K |
| Haywood County Community Hospital INC | Brownsville, TN | $491K |
| Houston County Community Hospital | Erin, TN | $416K |
| Lexington Hospital Corporation | Lexington, TN | $379K |
| Shamrock Community Hospital INC | Erin, TN | $315K |
| Decatur County General Hospital | Parsons, TN | $216K |
| Houston County Community Hospital | Erin, TN | $94K |
| Lexington Clinic Corp | Lexington, TN | $74K |
| Scotts Hill Clinic, INC. | Lexington, TN | $73K |
| Lexington Hospital Corporation | Brownsville, TN | $13K |
| Lexington Family Physicians LLC | Lexington, TN | $11K |
| Lexington Hospital Corporation | Lexington, TN | $953.55 |
| Shamrock Community Hospital INC | Erin, TN | $586.76 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.